New Drug Could Make Ears “Young” Again
Citrus, Berries, Broccoli Reduce Risk of Cancer and CVD
Changes in Antibiotic Recommendations for Children
Influences Gene Involved in Circadian Rhythms
‘The Perfect Drug for Trauma-Focused Psychotherapy’
Triggers the Body’s Own Natural Blood Flow Regulation
Inrebic Reduces Symptoms by 50% in Some Patients
Novel Catheter-based Technology for Treating Acute Ischemic Stroke
Decision supported by data from more than 4,000 patients

P&T August 2019 ePub
Table of Contents


Health Care & Law
How does the Patient Protection and Affordable Care Act (ACA) of 2010 differ from the act as it stands today? Many changes have occurred, in Medicaid expansion, private insurance coverage, the American Health Benefit Exchanges, and the individual mandate.
How a pharmacist-driven termination protocol effectively reduced the inappropriate use of acid-suppressive medications, with little impact on pharmacist workflow.
In the case of atypical, long-acting injectable (LAI) antipsychotics, billing under the medical benefit option can cause a significant financial loss. By switching to billing under the pharmacy benefit option, savings can be made in some cases when the use of LAIs and other costly medications is required.
Administering oncology medications has shifted from the inpatient to the outpatient setting because of new, minimal-toxicity regimens, rising drug costs, and a movement toward value-based care. As payer reimbursements decrease, healthcare organizations must find ways to reduce costs while maintaining high-quality services.


Prescription: Washington
Congressional deliberations over several competing bills on drug-price transparency may generate some useful data but are unlikely to have any effect on prices.
Medication Errors
Using chloral hydrate carries a risk of adverse events and compounding errors, and much of the available literature recommends using alternative sedatives for pediatric patients. But evidence regarding the efficacy of chloral hydrate and of alternative agents is conflicting.
Approvals, new indications and formulations, and safety issues
Drug Forecast
Perseris: A new, long-acting, atypical antipsychotic drug-delivery system

Industry announcements